Welcome to DrugBank 4.0! If you prefer, you can still go back to version 3.0.
Identification
Name3-Indolebutyric Acid
Accession NumberDB02740  (EXPT00173)
Typesmall molecule
Groupsexperimental
DescriptionNot Available
Structure
Thumb
SynonymsNot Available
SaltsNot Available
Brand namesNot Available
Brand mixturesNot Available
CategoriesNot Available
CAS number133-32-4
WeightAverage: 203.2371
Monoisotopic: 203.094628665
Chemical FormulaC12H13NO2
InChI KeyInChIKey=JTEDVYBZBROSJT-UHFFFAOYSA-N
InChI
InChI=1S/C12H13NO2/c14-12(15)7-3-4-9-8-13-11-6-2-1-5-10(9)11/h1-2,5-6,8,13H,3-4,7H2,(H,14,15)
IUPAC Name
4-(1H-indol-3-yl)butanoic acid
SMILES
OC(=O)CCCC1=CNC2=C1C=CC=C2
Mass SpecNot Available
Taxonomy
KingdomOrganic Compounds
SuperclassHeterocyclic Compounds
ClassIndoles and Derivatives
SubclassIndoles
Direct parentIndoles
Alternative parentsSubstituted Pyrroles; Benzene and Substituted Derivatives; Polyamines; Carboxylic Acids; Enolates
Substituentssubstituted pyrrole; benzene; pyrrole; carboxylic acid derivative; enolate; polyamine; carboxylic acid; organonitrogen compound
Classification descriptionThis compound belongs to the indoles. These are compounds containing an indole moiety, which consists of pyrrole ring fused to benzene to form 2,3-benzopyrrole.
Pharmacology
IndicationNot Available
PharmacodynamicsNot Available
Mechanism of actionNot Available
AbsorptionNot Available
Volume of distributionNot Available
Protein bindingNot Available
Metabolism
Route of eliminationNot Available
Half lifeNot Available
ClearanceNot Available
ToxicityNot Available
Affected organismsNot Available
PathwaysNot Available
SNP Mediated EffectsNot Available
SNP Mediated Adverse Drug ReactionsNot Available
ADMET
Predicted ADMET features
Property Value Probability
Human Intestinal Absorption + 0.9934
Blood Brain Barrier + 0.9789
Caco-2 permeable - 0.5427
P-glycoprotein substrate Non-substrate 0.7023
P-glycoprotein inhibitor I Non-inhibitor 0.9863
P-glycoprotein inhibitor II Non-inhibitor 0.9534
Renal organic cation transporter Non-inhibitor 0.8472
CYP450 2C9 substrate Non-substrate 0.8162
CYP450 2D6 substrate Non-substrate 0.8075
CYP450 3A4 substrate Non-substrate 0.7305
CYP450 1A2 substrate Non-inhibitor 0.7261
CYP450 2C9 substrate Non-inhibitor 0.8397
CYP450 2D6 substrate Non-inhibitor 0.947
CYP450 2C19 substrate Non-inhibitor 0.8916
CYP450 3A4 substrate Non-inhibitor 0.9402
CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.9181
Ames test Non AMES toxic 0.9559
Carcinogenicity Non-carcinogens 0.9566
Biodegradation Ready biodegradable 0.5241
Rat acute toxicity 2.0347 LD50, mol/kg Not applicable
hERG inhibition (predictor I) Weak inhibitor 0.9491
hERG inhibition (predictor II) Non-inhibitor 0.9446
Pharmacoeconomics
ManufacturersNot Available
PackagersNot Available
Dosage formsNot Available
PricesNot Available
PatentsNot Available
Properties
Statesolid
Experimental Properties
PropertyValueSource
melting point124.5 °CPhysProp
water solubility250 mg/L (at 20 °C)TOMLIN,C (1994)
logP2.30HANSCH,C ET AL. (1995)
Predicted Properties
PropertyValueSource
water solubility3.56e-01 g/lALOGPS
logP2.38ALOGPS
logP2.6ChemAxon
logS-2.8ALOGPS
pKa (strongest acidic)4.86ChemAxon
physiological charge-1ChemAxon
hydrogen acceptor count2ChemAxon
hydrogen donor count2ChemAxon
polar surface area53.09ChemAxon
rotatable bond count4ChemAxon
refractivity57.65ChemAxon
polarizability22.03ChemAxon
number of rings2ChemAxon
bioavailability1ChemAxon
rule of fiveYesChemAxon
Ghose filterYesChemAxon
Veber's ruleNoChemAxon
MDDR-like ruleNoChemAxon
Spectra
Spectra
References
Synthesis ReferenceNot Available
General ReferenceNot Available
External Links
ResourceLink
KEGG CompoundC11284
PubChem Compound8617
PubChem Substance46505244
ChemSpider8298
ChEBI33070
ChEMBL
HET3IB
ATC CodesNot Available
AHFS CodesNot Available
PDB Entries
FDA labelNot Available
MSDSNot Available
Interactions
Drug InteractionsNot Available
Food InteractionsNot Available

1. Aromatic-amino-acid aminotransferase

Kind: protein

Organism: Paracoccus denitrificans

Pharmacological action: unknown

Components

Name UniProt ID Details
Aromatic-amino-acid aminotransferase P95468 Details

References:

  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. Pubmed
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. Pubmed
  3. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. Pubmed

2. Beta-2-microglobulin

Kind: protein

Organism: Human

Pharmacological action: unknown

Components

Name UniProt ID Details
Beta-2-microglobulin P61769 Details

References:

  1. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. Pubmed

3. T-cell receptor alpha chain C region

Kind: protein

Organism: Human

Pharmacological action: unknown

Components

Name UniProt ID Details
T-cell receptor alpha chain C region P01848 Details

References:

  1. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. Pubmed

4. T-cell receptor beta-1 chain C region

Kind: protein

Organism: Human

Pharmacological action: unknown

Components

Name UniProt ID Details
T-cell receptor beta-1 chain C region P01850 Details

References:

  1. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. Pubmed

5. HLA class I histocompatibility antigen, A-2 alpha chain

Kind: protein

Organism: Human

Pharmacological action: unknown

Components

Name UniProt ID Details
HLA class I histocompatibility antigen, A-2 alpha chain P01892 Details

References:

  1. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. Pubmed

Comments
Drug created on June 13, 2005 07:24 / Updated on September 16, 2013 17:18